
Novartis Phase III APPOINT-PNH trial shows
Novartis Phase III APPOINT-PNH trial shows investigational oral monotherapy iptacopan improves hemoglobin to near-normal levels, leading to transfusion independence in all treatment-naïve PNH patients Novartis today announced detailed results from the Phase III APPOINT-PNH trial of investigational oral monotherapy iptacopan…